Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-12-000006

CEO bought 10,000 shares at an average $0.52 ($5,155)

From the SEC's structured data for this filing

Trades in this filing

Babcock Dwight William · CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2012-03-22 Purchase : show line 1 in the form +4,900 $0.53 $2,585 201,273 D
2012-03-22 Purchase : show line 2 in the form +100 $0.50 $50 201,373 D
2012-03-22 Purchase : show line 3 in the form +1,000 $0.52 $520 202,373 D
2012-03-20 Purchase : show line 4 in the form +4,000 $0.50 $2,000 206,373 D
Open-market purchases · 10,000 sh · avg $0.52 · $5,155
Loading xslF345X03/primary_doc.xml…